Details for New Drug Application (NDA): 011361
✉ Email this page to a colleague
The generic ingredient in TRILAFON is perphenazine. There are eight drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the perphenazine profile page.
Summary for 011361
Tradename: | TRILAFON |
Applicant: | Schering |
Ingredient: | perphenazine |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 011361
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 8MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription